title: J&J in talks to acquire Protagonist Therapeutics
source: Yahoo
date: 2025-10-13
url: https://finnhub.io/api/news?id=f95253498999cb5c06f0acf047271f687db67847965de7edccdcaa90335c478c
The acquisition would grant J&J access to rusfertide, which has demonstrated promise in late-stage trials for polycythaemia vera.
